Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO).

Date publication

juin 2018

Journal

The oncologist

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CHAIGNEAU Loïc , Pr NERICH Virginie

Tous les auteurs :
Chaigneau L, Patrikidou A, Ray-Coquard I, Valentin T, Linassier C, Bay JO, Moureau Zabotto L, Bompas E, Piperno-Neumann S, Penel N, Alcindor T, Laigre M, Guillemet C, Salas S, Hugli A, Domont J, Sunyach MP, Lecesne A, Blay JY, Nerich V, Isambert N

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29934413

Résumé

Brain metastases (BM) from adult soft tissue or bone sarcomas are rare, and sparse data exist on their prognostic factors and management.

Mots clés

Brain metastases, French Sarcoma Group, Prognostic factors, Sarcoma

Référence

Oncologist. 2018 Jun 22;: